Studies on the bioequivalence of domestic terazosin tablet in healthy volunteers

Chinese Pharmaceutical Journal

Volumn 38, Issue 6, 2003, Pages 446-448

  Chen, Jun ^a   Lu, Wei ^a   Gao, Ke pan ^a   Shi, Zhen qi ^a   Jiang, Xin guo ^a   Rong, Zheng xing ^b   Chen, Hong zhuan ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

HPLC; Relative bioavailability; Terazosin hydrochloride

Indexed keywords

BODY FLUIDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHARMACOKINETICS;

BIOEQUIVALENCE;

DRUG PRODUCTS;

TERAZOSIN;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG HALF LIFE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PARAMETER; RANDOMIZED CONTROLLED TRIAL; TABLET FORMULATION;

EID: 0041589855     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Phaik YC, Kah HY, Men LL. Improved high-performance liquid chromatographic analysis of terazosin in human plasma [J]. J Chromatogr B Biomed Appl, 2000,745:439.
2. Zavitsanos AP, Alebic K. Enantioselective determination of terazosin in human plasma by normal phase high-performance liquid chromatography-electrospray mass spectrometry [J]. J Chromatogr, 1998,794:45.
3. Bhamra RK, Flanagan RJ. HPLC measurement of prazosin and terazosin in biological fluid[J]. J Chromatogr, 1986,380:216.
4. Chandra Se, Rao TR. Determination of terazosin in human plasma, using HPLC with fluorescence detection[J]. J Chromatogr B Biomed Appl, 1998,710:137.